The Latest in Rheumatology

Internal Medicine News

Switch to biologic for RA more about prescribers than patients

December 13, 2019

Rheumatology

Internal Medicine News

Repeat LTBI testing best in patients taking biologics with new risk factors

December 9, 2019

Internal Medicine News

Updated gout guidelines: Don’t let kidney function dictate allopurinol dosing

December 9, 2019

Rheumatology

Internal Medicine News

FDA approves infliximab-axxq for numerous indications

December 6, 2019

Internal Medicine News

Certolizumab may reduce uveitis flares, axSpA disease activity

December 6, 2019

Rheumatology

Internal Medicine News

TULIP trials show clinical benefit of anifrolumab for SLE

December 5, 2019

Rheumatology

Internal Medicine News

Study shows comparable outcomes for total hip arthroplasty vs. hemiarthroplasty

December 4, 2019

Rheumatology

Internal Medicine News

Upadacitinib doubles ASAS 40 response vs. placebo in ankylosing spondylitis

December 3, 2019

Rheumatology

Internal Medicine News

Certolizumab safety profile varies widely across indications

November 27, 2019

Internal Medicine News

OA management guidelines forgo treatment hierarchy or order but emphasize severity, patient risk factors

November 24, 2019

Internal Medicine News

Large population-based study underscores link between gout, CVD event risk

November 23, 2019

Internal Medicine News

Newer IL-17 inhibitors make their case in phase 3 nonradiographic axial spondyloarthritis trials

November 21, 2019

Rheumatology

Internal Medicine News

Fewer people are dying from systemic sclerosis at younger ages

November 21, 2019

Internal Medicine News

Rituximab tops azathioprine for relapsing ANCA-associated vasculitis remission maintenance

November 21, 2019

Rheumatology

Internal Medicine News

Novel antibody looks promising in lupus nephritis

November 19, 2019